-+ 0.00%
-+ 0.00%
-+ 0.00%

Moderna's Updated COVID-19 Vaccine Gets Canadian Regulatory Nod

MT Newswires·08/22/2025 10:15:17
Listen to the news
10:15 AM EDT, 08/22/2025 (MT Newswires) -- Biotechnology company Moderna's (0QF.F) updated formulation of its COVID-19 vaccine received authorization from Health Canada. The approval marks the first time that Spikevax pre-filled syringe doses will be produced locally, according to a Friday release. The Canada-made doses are expected to be available in the fall. The updated mRNA vaccine, targeting the SARS-CoV-2 LP.8.1 variant, is on track for delivery in the 2025-2026 vaccination season.